Epidemiological studies of medical radiation workers have found excess risks of leukemia, skin and female breast cancer in those employed before 1950 but little consistent evidence of cancer risk increases subsequently. Occupational radiationrelated dose-response data and recent and lifetime cancer risk data are limited for radiologists and radiologic technologists and lacking for physicians and technologists performing fluoroscopically guided procedures. Survey data demonstrate that occupational doses to radiologists and radiologic technologists have declined over time. Eighty mostly small studies of cardiologists and fewer studies of other physicians reveal that effective doses to physicians per interventional procedure vary by more than an order of magnitude. For medical radiation workers, there is an urgent need to expand the limited information on average annual, time-trend and organ doses from occupational radiation exposures and to assess lifetime cancer risks of these workers. For physicians and technologists performing interventional procedures, more information about occupational doses should be collected and long-term follow-up studies of cancer and other serious disease risks should be initiated. Such studies will help optimize standardized protocols for radiologic procedures, determine whether current radiation protection measures for medical radiation workers are adequate, provide guidance on cancer screening needs, and yield valuable insights on cancer risks associated with chronic radiation exposure. g 2010 by Radiation 
INTRODUCTION
Radiation has been used in medical practice for more than a century. For close to seven decades, the use of ionizing radiation in medicine was mostly limited to radiologists, radiation oncologists and associated technical personnel. Since the mid-1960s, technological developments in diagnostic imaging, radiotherapy, catheters and other devices used in fluoroscopically guided interventional and nuclear medicine procedures have revolutionized medical practice but have increased the potential for radiation exposure. The advent of catheters led to exponentially increasing diagnostic and therapeutic fluoroscopically guided radiologic procedures carried out by cardiologists and expanding numbers of other physician specialists in addition to radiologists. Workers using radiation in medical practice now comprise more than half of all radiation workers exposed to man-made sources of radiation (1) .
Shortly after the discovery of X rays and their early use in medicine, adverse biological and clinical effects, including cancer, were observed among physicians using the new technology [reviewed in refs. (2, 3) ]. Cancer risks associated with single acute or fractionated high-dose radiation exposures have been studied extensively in the Japanese atomic bomb survivors (4) and in cohorts of patients treated for benign and malignant conditions [reviewed in ref. (5)], respectively. The most common form of exposure to the general population, however, is from chronic or fractionated low-dose radiation exposure from medical and natural background sources. Natural environmental background sources (e.g., residential radon, cosmic rays) comprised the majority of ionizing radiation exposures to the general population prior to 1980. The dramatic increases from medical sources in the past 30 years (when the U.S. per capita dose rose close to 600% and the population collective dose more than 700%, mostly due to computed tomography and nuclear medicine scans), have resulted in similar levels of population exposure from medical radiation sources as from environmental radiation (6) .
Occupational cohorts have been particularly important for the study of cancer risks after chronic or fractionated low-dose exposure. The largest categories of radiation-exposed workers are nuclear industry (7, 8) and medical radiation workers (9, 10) . Medical radiation workers generally experience very low radiation exposures, except for those performing certain fluoroscopi-cally guided procedures and potentially those administering radionuclides for nuclear medicine procedures. Current estimates of cancer risks from low-and moderate-dose exposures are mostly based on risk estimates from extrapolation of data on the Japanese atomic bomb survivors. Laboratory animal and radiobiological data have been used to derive estimates for a dose and dose-rate effectiveness factor to reduce the risk values for the atomic bomb survivors to estimate more accurately the cancer risks associated with low-and moderate-dose radiation exposures (11, 12) . A recent meta-analysis of 12 epidemiological studies of populations experiencing low-and moderate-dose radiation exposures primarily from occupational sources suggests that the cancer risk per dose for these exposures is not lower than that for the atomic bomb survivors as has commonly been assumed (13) .
In this review we focus on cancer and related risks in workers performing diagnostic radiology and fluoroscopically guided procedures but not nuclear medicine procedures because of the paucity of clinical, epidemiological and dosimetry studies of the latter as well as the complexity of estimating doses. We briefly review the history of key discoveries and technological developments and clinical reports and major epidemiological studies assessing cancer risks in medical radiation workers. Because historical reconstruction of individual dosimetry is difficult and most of the epidemiological studies do not include individual dosimetry, we report published estimates of average annual film badge measurement survey data and summarize time trends in these measurements in medical radiation workers. We identify limitations and gaps in cancer risk estimates and occupational dosimetry of medical radiation workers and propose future research initiatives.
HISTORICAL BACKGROUND
The discoveries of X rays, radium and radioactivity from uranium salts by Roentgen, Becquerel and the Curies during the late 19th century heralded a new era in medical diagnosis and treatment. Their pioneering work initiated remarkable experimental, clinical and technological developments in radiologic imaging that have continued to transform medicine for more than a century and influenced occupational as well as patient radiation exposures from radiologic procedures. Key historical discoveries and technical developments in diagnostic radiography are summarized in Table 1a (14, 15) .
Within a few years of the development of the X-ray tube by Roentgen, the fluoroscope enabled real-time medical imaging without the need for processing of a film or X-ray plate (14) . Fluoroscopy competed successfully with radiography for several years until technical limitations and associated serious health effects, including radiation ''burns'' and deaths from acute leukemia, led to a decline in its use. Military needs at the onset of World War I in conjunction with important technical advances (see Table 1a ) resulted in re-emergence of fluoroscopy. The value of this type of diagnostic imaging was underscored in the 1930s with recognition of the relatively low error rate associated with fluoroscopy for detection of tuberculosis. Development of the image intensifier in 1948 and other notable advances led to expansion in the use of fluoroscopy in medicine and to the new specialty of interventional radiology in the 1960s. Interventional radiology is defined as manipulative diagnostic or therapeutic procedures controlled and followed under fluoroscopic guidance (16) . Although initially carried out mostly by radiologists, fluoroscopically guided interventional procedures have increasingly been performed by cardiologists, with the introduction of cardiac catheters for surgical interventions (17) , and by vascular surgeons, gastroenterologists, urologists and a growing number of other specialists. Whereas many of the developments highlighted in Table 1a have resulted in reduced occupational radiation exposures (Fig. 1) , this has not necessarily been the case for fluoroscopically guided procedures (10) . Key historical discoveries and 
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developments in interventional radiology are summarized in Table 1b ( .
INITIAL REPORTS OF ADVERSE BIOLOGICAL AND CLINICAL EFFECTS IN MEDICAL RADIATION WORKERS
Within a few years of Roentgen's discovery of X rays in 1895, a growing number of short-term (e.g., dermatitis, skin ulceration, epilation, eye irritation) and longer-term (e.g., cataracts, skin carcinomas and other cancers) adverse biological effects were identified. A summary of the initial clinical reports of cancer and other serious diseases in medical radiation workers is shown in Table 2 . Clinical reports on skin cancer (40, 41) , leukemia (42) (43) (44) (45) (46) (47) (48) (49) and aplastic anemia (49, 50) (Table 2 ) motivated epidemiologists to undertake systematic follow-up studies of cohorts of radiologists and radiologic technologists in the 1950s and early 1960s (51, 52) .
RADIOLOGISTS AND RADIOLOGICAL TECHNOLOGISTS

Clinical and Epidemiological Studies
Several epidemiological studies have linked registries of physicians with population-based mortality or cancer incidence data and reported data separately for radiologists (53) (54) (55) . Members of the American College of Radiology who joined this professional society during 1962-1977 and were born before 1920 experienced a significantly higher total mortality than pathologists who joined the College of American Pathologists during 1962-1977 and were born before 1920, although ageadjusted mortality rates were lower among members of both professional societies who joined after 1962 than among those joining these societies earlier (53) . Among 1,589 radiologists and radiotherapists in the United Kingdom (UK), neither total mortality nor total cancer mortality was significantly higher than in other physicians during the follow-up period of 1962-1992, although deaths from respiratory diseases were significantly elevated (54) . Follow-up of 1,312 physicians using radiation compared with physicians never monitored for radiation exposure in Finland revealed similar total cancer incidence, and a slightly elevated risk of breast cancer but no other cancer excesses or radiation dose response associated with cancer risks (55) . None of these studies adjusted for birth cohort effects, although Jartti et al. (55) assessed risks according to year of birth.
Eight major cohorts have been actively followed up for cancer and other serious disease occurrence, evaluated in detail, and/or characterized with group or individual dose estimates (9, 51, 52 , 56-68) . The eight cohorts include British (51, 56, 57) , U.S. radiologists (52, 58, 59) , U.S. radiologic technologists (60-63), U.S. Army technologists (64) , Japanese technologists (65), Chinese medical X-ray workers (66) , Danish radiotherapy workers (67) , and Canadian medical radiation workers (68) . Details from the epidemiological followup are summarized in Table 3a and 3b; dose data are provided in Tables 4 and 5 . Collectively, the eight retrospective cohort investigations have studied radiologists or radiologic technologists who first began working over a period spanning more than 80 years, including small numbers who first began working in the earliest years of the professions (e.g., between 1897 and 1926). From the eight cohort studies, notable excess leukemia mortality risks were observed in UK (51, 57) and U.S. radiologists (52, 58, 59 ) who first worked before or during the 1920s. Smaller albeit elevated risks were seen in UK radiologists who worked in subsequent decades (56) . Significantly elevated incidence risks of leukemias other than chronic lymphocytic leukemia were seen in U.S. radiologic technologists who worked 5 or more years before 1950 (63) . In addition, the incidence of leukemia in Chinese X-ray workers who worked before 1970 was significantly higher than expected (66) . Estimated risks for skin (57, 59, 66, 67) and female breast cancer (60) (61) (62) (66) (67) (68) varied by study and years of employment. Findings for other solid tumors were not as consistent in the medical radiation worker cohorts (9, 68) ( Table 3 ).
Dosimetry and Radiation Protection Measures
Most of the epidemiological studies of medical radiation workers do not report individual dosimetry and none have described lifetime estimated dose data. Various metrics of exposure and dose have been used over the years to describe occupational exposure, which Table 5 .
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complicates efforts to summarize temporal trends from the literature. Metrics used in the literature included nonquantitative measures based on skin erythema, exposure (R), air kerma (rad or Gy), which may or may not include backscatter, entrance surface dose (which again may or may not include backscatter), some form of equivalent dose (rem or Sv), which may be calibrated in terms of ''deep dose'' (10-mm depth in tissue) or shallow dose (0.07-mm depth in tissue) or not clearly defined. Measurements from personal monitor- Frieben, 1902 (40) Cancer arising in skin ulcer Rollins, 1901 Rollins, -1904 Multiple health hazards of X rays and need for radiation protection Scott, 1911 (42) X-ray dermatitis and fatal skin cancers Von Jagic et al., 1911 (43) Leukemia in five medical radiation workers Henshaw and Hawkins, 1944 (44) Increased occurrence of leukemia in radiologists March, 1944 (45) ; March, 1950 (47) ; March, 1961 (48) Higher proportionate mortality from leukemia in radiologists Ulrich, 1946 (46) Higher proportionate mortality from leukemia in radiologists Lewis, 1963 (49) Excess mortality from leukemia, aplastic anemia and multiple myeloma in radiologists compared with expected death rates in U.S. while male population of same age and year of death Kitabatake et al., 1976 (50) Excess aplastic anemia in Japanese radiologic technologists compared with general population Vañ ó et al., 1998 (100) Cataracts in interventional radiologists Finkelstein, 1998 (101) Brain tumors in cardiologists performing interventional procedures: clinical reports Wenzl, 2002 (102) Brain tumors in physicians performing interventional radiology procedures: literature review
Note. Sources: Seibert (15), Yoshinaga (9), DiSantis (2).
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ing devices (e.g., film badges) are usually reported as equivalent dose (mrem or mSv), specified as deep or shallow, while exposure guidelines since the late-1970s have been couched primarily in terms of effective dose equivalent (Table 5) . Effective dose, a quantity developed by the International Commission on Radiological Protection (ICRP) for radiation protection purposes, is derived from a weighted sum of doses to tissues known to be sensitive to radiation (11, 69) . Effective dose relates only to reference persons and is derived using dose coefficients that have no associated uncertainty. Some publications do not clearly describe the appropriate dose metrics; for example, effective dose estimates are reported as if lead aprons had not been used when in fact they were used. Table 5 summarizes historical changes in estimated occupational doses of medical radiation workers, although there is some inconsistency in the reported values. In this paper, use of the term ''occupational dose'' does not refer to specific units but refers in general to equivalent dose for individuals and to effective dose when discussing exposure limits. In all cases, it should be recognized that reports of estimated or reported doses may or may not have accounted for the use of protective lead aprons, shields or other protective devices. An important weakness of most dosimetric data for the purposes of epidemiological study is that the absorbed doses to most organs or tissues are not well represented by effective doses or even by the equivalent doses derived from personal monitoring devices.
Absorbed dose would be best approximated by the values from personal monitoring devices for relatively shallow organs, including skin, thyroid and breast (if not covered by a protective apron or thyroid shield). Although some type of individual dosimetric data is needed from which organ doses can be estimated to derive radiation dose response in relation to cancer and other serious disease risks, effective dose is not an appropriate quantity for assessing occurrence and severity of tissue reactions (deterministic effects) at high doses or for assessing radiation-related dose response (70) . Tables 3a and 3b. Tables 3a and 3b were modified from Yoshinaga et al. (9) and Zielinski (68). a Abbreviations: SMR 5 standardized mortality ratio; SIR 5 standardized incidence ratio; NA 5 not available. b The comparison group is shown for total mortality/incidence, total cancer mortality/incidence, and for leukemia. Unless specified, the comparison group is the same for skin cancer and for other cancers. Cross-sectional data from studies carried out in hospitals or from national surveys, radiation registries and large film badge measurement companies during different periods allow estimation of occupational effective dose ranges and temporal trends in effective doses. Figure 1 depicts literature derived estimated annual occupational effective radiation doses and temporal trends in average effective doses to radiologists (1, (71) (72) (73) (74) (75) (76) (77) (78) (79) (80) , which are compared with National Council on Radiation Protection and Measurements (NCRP) recommendations for occupational limits, based on effective dose (81, 82) . Estimated badge doses during calendar year periods from 1926 through 1984 are shown in Table 4 for U.S. radiologic technologists.
Radiologists
Only limited measurements and estimated doses to radiologists were available before 1940. Estimated effective doses ranged from 900 to 7,000 mSv/year during the 1920s (71) (72) (73) , were generally in the range of 50 to 100 mSv/year before 1950 (57, 74) , and were approximately 50 mSv/year in the early 1950s (75), although some institutions described a broader range of radiation doses with higher levels characterizing those handling radium (76) . Annual effective doses to medical radiation workers decreased notably from less than 5 mSv in the early 1960s to 1 mSv in the 1970s, 0.75-0.34 mSv in the 1980s, 0.55-0.12 mSv in the 1990s, and 0.23-0.08 mSv after 2000 (see Fig. 1) (1, 77-80) . Interpretation of reports of temporal changes in effective radiation doses must also consider changes over time in the definition of effective dose, and the numerical values of the tissue weighting factors. Although the early hospital-based dose data are from the U.S., after 1957 most of the data shown in Fig. 1 are from the UK, Canada or other countries.
U.S. radiologic technologists
Estimated average annual uncertainty distributions of badge doses assigned to members of the U.S. radiologic technologist cohort who worked in hospitals during 1926-1984 are shown in Table 4 . The dose distribution estimates were derived from 350,000 film badge measurements for individual radiologic technologists, work history and protection-related data from questionnaires, and measurement and other data derived from the literature. During the five calendar-year periods shown, the mean annual estimated badge doses (dose equivalent) declined notably from an estimated 100 mSv before 1939 to 2.3 mSv during 1977-1984 (83) . Badge doses were used to estimate organ absorbed doses for each technologist in the cohort for eight different tissues (83) . The dose estimation strategy was based on the sequential conversion of badge dose (mSv) to air kerma (mGy), followed by the conversion to organ dose (mGy), assuming anterior to posterior irradiation geometry, energies typical of diagnostic X-ray examinations, and use of protective aprons (the latter based on questionnaire data). Conversion factors for air kerma to organ dose and estimation of the level of protection afforded by lead aprons were derived from ICRP data (84) but integrated over X-ray energy spectra typical of different decades (85).
History of radiation protection
Increasing recognition of serious morbidity and mortality associated with external and internal sources of radiation (3) led to formation of international and national Advisory Committees on X-ray and Radium Protection in 1928 and 1929, respectively (86-90) (see Table 5 ). Recommended occupational exposure limits have changed over time as new information becomes available on the biological and health effects of radiation. The 1930s concept of tolerance dose (a dose to which workers could be exposed continuously without any evident deleterious acute effects such as skin erythema) evolved in the 1950s to maximum permissible dose (a dose associated with a low probability of adverse health effects including late effects). In 1957, the recommended maximum permissible occupational dose was reduced substantially to an upper limit of 50 mSv (5 rem) annually. In the U.S., advice and recommendations for occupational exposure limits have been provided by the National Council on Radiation Protection and Measurements (NCRP) since 1946, whereas legal responsibility for implementation of radiation safety is the responsibility of the Nuclear Regulatory Commission, the Department of Energy, and state or city bureaus of radiation control. Internationally, the International Commission on Radiation Protection (ICRP) generally develops concepts relevant to radiation protection and recommends dose limits. ICRP recommendations carry substantial weight but are not legally binding. Important scientific committees that analyze key available data and suggest risk limits for radiation-induced cancer and other serious health effects include the United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR), which has issued comprehensive reports since 1958, and the Biological Effects of Ionizing Radiation (BEIR) Committee appointed by the U.S. National Academy of Sciences, which has issued reports since 1956. In the U.S., recommended effective dose levels for medical radiation workers have not changed since the 1957 recommendation of 50 mSv annually, although the ICRP recommended reducing the annual limits of 20 mSv per year averaged over 5 years in 1991 (69) .
Initial radiation protection efforts were largely directed at limiting exposures of medical radiation workers (11, 69, 91) , whereas subsequent recommendations and regulations were developed for both occupationally and non-occupationally exposed populations. Radiation protection efforts were complicated by difficulties in measuring exposures, in determining ''safe levels'' due to the delayed nature of most serious health effects, and in developing a systematic approach to standardizing radiation protection limits (92) . Overall, however, the time trend effective dose data for radiologists and radiologic technologists are generally reassuring in demonstrating that occupational exposures of these workers have declined dramatically over time ( Fig. 1 and Table 4 ) despite the substantial increase in medical radiation procedures over time, particularly during the past 30 years (93). The descriptive data in Fig. 1 for radiologists do not include specific information on estimated doses of interventional radiologists or for the increasing numbers of other non-radiologist medical specialists who carry out fluoroscopically guided procedures. The dose data in Table 4 reflect estimates for a large cohort of radiologic technologists through 1984, and doses continued to decline notably through the end of the 1990s (85).
Limitations and Current Status
Follow-up for the U.S. radiologist and U.S. Army technologist cohorts ended in the mid-1970s (59, 64) , for the Danish cohort in the mid-1980s (67) , and for the UK radiologists and the Japanese and Chinese cohorts in the mid-1990s (56, 65, 66) (see Table 6 ). The mortality outcomes reported in the studies of U.S. and UK radiologists, the U.S. Army radiologic technologists, and the U.S. radiologic technologists are limited in the ability to assess risks for cancers with low fatality rates, and all of these populations with the exception of the U.S. radiologic technologists included only male medical radiation workers. Studies of cancer incidence in the U.S. radiologic technologists provide information on less highly fatal cancers such as breast cancer (62) . There is currently no active follow-up for the major medical radiation worker cohorts except for the Canadian medical radiation workers (68, 94, 95 ) and the U.S. radiologic technologists (http:// radtechstudy.nci.nih.gov). To date there have been no epidemiological studies of cancer risks for medical radiation workers performing or assisting with the newer, higher-dose radiologic procedures including fluoroscopically guided interventional procedures. Another important limitation in some of these studies is that follow-up of workers ended before the majority of medical radiation workers attained ages at which cancer risks are the highest. Additionally, there has been extremely limited study of female radiologists and their risk for breast, thyroid and other cancers. Also, some of the epidemiological studies lacked internal comparison of risks and most lack individual dose data.
PHYSICIANS AND RADIOLOGIC TECHNOLOGISTS PERFORMING FLUOROSCOPICALLY GUIDED PROCEDURES
Clinical and Epidemiological Studies
Although the decline in estimated annual average effective dose data for radiologists and radiologic technologists has been dramatic, this may not be the case for physicians performing fluoroscopically guided procedures (10) . Unlike medical radiation workers carrying out other diagnostic procedures such as CT scans, staff performing fluoroscopically guided procedures are nearly always present in the room close to the patient and the X-ray imager, and it is difficult to avoid exposure to radiation scatter. A rapidly expanding number of physicians in other specialties, often with little or no training in radiation protection, have been conducting fluoroscopically guided interventional procedures in both developed and developing countries (39, 96, 97) . There are now more cardiologists than radiologists in the UK being monitored for occupational radiation exposure (80) , and this is probably true for other developed countries. Increasingly complex fluoroscopically guided interventional procedures have To compare the reported radiation doses, the original dose units (e.g., skin unit dose, R, etc.) were roughly approximated to current dosimetry units (e.g., mSv).
b The unit of absorbed dose (e.g., rad or Gy) was not defined in 1902. The estimated dose in Gy is an interpretation in modern dose units of the measurement capability at that time based on fogging on a photographic plate.
CANCER IN MEDICAL RADIATION WORKERS 801 been undertaken on growing numbers of patients, thus requiring longer fluoroscopy time (98, 99) .
Despite clinical reports of cataracts (100) and brain tumors (101, 102) among physicians performing fluoroscopically guided procedures, there has been no longterm epidemiological cohort study, although projections of cancer risk have been carried out based on dosimetry data from small numbers of workers (103) . A relatively short-term mortality follow-up through 2003 was undertaken to evaluate risks in U.S. radiologic technologists assisting with fluoroscopically guided interventional procedures (104) . Work history (including the frequency of assisting with interventional procedures before 1980, during 1980-1989 or in 1990 or later) was ascertained among 88,766 technologists using a selfadministered questionnaire completed during 1994-1998. The technologists were followed up for mortality through 2003. Compared with radiologic technologists who rarely or never assisted with fluoroscopically guided interventional procedures, risks among those who daily assisted with such procedures were not significantly increased for mortality from all causes [relative risks (RR) were 0.9 (95% CI 5 0.7-1.0), 1.2 (95% CI 5 0.9-1.5), and 1.0 (95% CI 5 0.7-1.4) for those performing these procedures before 1980, during 1980-1989 and in 1990 or later), all cancers (RR 5 0.8, 1.1 and 1.1 during these same periods), or all circulatory system diseases (RR 5 1.0, 1.3 and 9.9), but there were nonsignificant increases in mortality from cerebrovascular disease [RR 5 1.4 (95% CI 5 0.8-2.4), RR 5 1.1 (95% CI 5 0.4-2.7), and RR 5 1.7 (95% CI 5 0.6-4.4)]that were observed among technologists who ever performed or assisted with these procedures. However, the numbers were too small for assessing daily performance of these types of procedures.
Dosimetry and Radiation Protection Recommendations
Occupational radiation exposures to physicians performing fluoroscopically guided interventional procedures have been studied for more than 30 years (105), but most focused on dose per procedure rather than annual or cumulative doses. The estimates from these studies have been difficult to compare due to a number of factors discussed above, including different metrics of dose and different ways of calculating or estimating exposures. Partly for this reason, but also because of differences in work practices, reported doses have been observed to vary by more than an order of magnitude among studies (10, 106) . Some of the difficulties in comparing dose estimates among publications and work facilities and over time can be attributed to differences in dose metrics used and differences in dose computation or estimation techniques. Assessment of dose trends is also complicated by lack of systematic placement of film badges on the operator's body and/or failure to wear film badges (107) as confirmed by biological dosimetry (108) . When doses are estimated based on work practices or jobs, there are clearly difficulties in identifying and quantifying the predictive value of multiple factors Canadian) describe only badge dose data -All but one study describe only occupational exposure data 802 influencing doses such as fluoroscopy system operation and radiation protection measures (10) .
A recent comprehensive and systematic summary of the reported occupational radiation doses received by operators performing diagnostic or interventional fluoroscopically guided cardiac catheterization procedures found effective doses per procedure ranging from 0.02 to 38.0 mSv for diagnostic catheterization, 0.2-31.2 mSv for percutaneous coronary interventions, 0.2-9.6 mSv for ablations, and 0.3-17.4 mSv for pacemaker or intracardiac defibrillator implantations (10) (Fig. 2) . As the basis for estimating those effective doses, data on personal dose equivalent per procedure, as measured by monitoring devices placed either over or under protective aprons, were compiled. The measurements over personal protective devices ranged from 0.4-1,100 mSv at eye level, 1.2-580 mSv at thyroid level, 32-750 mSv at trunk level, and 0.4-790 mSv at hand level, whereas measurements under the apron at the trunk level ranged from 0 to 23 mSv (10) .
Assessment of time trends in cardiac procedures revealed modest albeit significant reductions in average dose for diagnostic catheterization and ablation. For percutaneous coronary interventions, there was some evidence of increasing operator dose over time. Changes over time in radiation doses to patients or operators may be due to changes in procedure protocols and technology. Improvements in procedure protocols and the technology of X-ray equipment, catheters and other devices generally decrease the time required for procedures (due to decreased fluoroscopy or cineradiography time) and may result in lower radiation doses for procedures with similar complexity. On the other hand, improved protocols and technologies make it possible to carry out more complex procedures, which can require longer fluoroscopy or cineradiography time or both. The increase in radiation associated with more complex procedures may negate the effect of technological improvements that might otherwise result in reduction of operator dose (98, 99) .
Although the numbers of dosimetry studies are substantially less for fluoroscopically guided interventional procedures carried out by specialists other than cardiologists, in general the same degree of variation in dose per procedure is apparent for nephrostomy and stone (109, 110) , vertebroplasty (111, 112) , transjugular intrahepatic portosystemic shunt (113) , and others.
The wide variation in operator dose suggests that reduction in operator dose should be possible by incorporating standardized protocols, personal protective gear and shields, and better physician training into practice (10) . Since doses to operators performing fluoroscopically guided interventional procedures correlate highly with patient doses (114, 115) , techniques that reduce patient dose will also tend to reduce worker dose. These include improvements in dose reduction technology for fluoroscopes and radiation management training for all operators. At present, operators in some medical specialties receive relatively little training in radiation management. There is also opportunity for improvement in occupational dosimetry. For example, there is no standardized national or international method that is employed to estimate effective occupational radiation dose for operators who perform fluoroscopically guided interventions (116) . NCRP Report No. 122 (116) provides recommended methods that could be adopted to estimate doses of these medical radiation workers. Methods to improve compliance with monitoring are also needed because reliable dosimetry is not possible unless monitors are worn regularly and consistently.
Limitations and Current Status of Epidemiological and Dosimetric Research
The single epidemiological cohort study of radiologic technologists performing or assisting with fluoroscopically guided procedures reported to date involved relatively short follow-up, did not include incidence data, and lacked individual technologist dose information (104) . In addition, the exposures of radiologic technologists assisting with fluoroscopically guided procedures are likely to differ from those of physicians performing such procedures. A comprehensive literature review of occupational dose data reveals substantial numbers of studies reporting dose per procedure to cardiologists but more limited assessment of dose per procedure for interventional radiologists and physicians other than cardiologists who perform fluoroscopically guided procedures. The data reveal enormous variation in the dose received by the operator per procedure and suggest that operator dose depends on numerous factors, but the contribution of each specific determinant has not been well quantified. Most dosimetry investigations have studied a relatively small number of operators and hospitals and thus provide little information about geographic variation on a national or international basis. Data are limited on the numbers of procedures performed annually per specialist or on the variability in the workload according to type of procedure for the different categories of physicians who carry out fluoroscopically guided procedures.
Cumulative occupational dose data are lacking, a problem that has been complicated by the substantial proportions of operators who rarely or never wear their dosimeters (108, 117) . Few efforts have been undertaken to calculate organ doses of operators from the occupational monitoring dose. Estimation of organ doses requires information about radiation geometry, X-ray energy and spectral characteristics, and use of protective clothing, which is often lacking on an individual basis.
FUTURE DIRECTIONS
Growing concern about the effects of chronic radiation exposure (118) , the dramatic increases in per capita dose from medical sources of radiation exposure (6, 93, 119) , the increasing numbers of radiologists (120) and other specialties of physicians and other medical workers who perform or assist with fluoroscopically guided interventional procedures (11, 121) , the growing workload of radiologists (122) and likely also that of physicians performing fluoroscopically guided procedures, and the limited numbers or lack of long-term epidemiological follow-up studies to assess cancer risks in radiologists, physicians performing fluoroscopically guided procedures and associated technologists, respectively, underscores the need for additional and improved occupational radiation dose monitoring and epidemiological research to estimate cancer and other serious disease risks of medical radiation workers. To this end, nationwide monitoring surveys should be carried out regularly in all major categories of medical radiation workers to ascertain average annual occupational radiation doses, dose trends and the types and numbers of procedures performed monthly by medical radiation workers. Efforts should be implemented to achieve 100% occupational radiation dose monitoring for these workers and to consistently record and to maintain long-term dosimetry and procedure records (e.g., the numbers and types of procedures performed). The dose monitoring and work procedure data should be used to estimate ranges of organ doses which will be critical to carry out radiationrelated risk assessments for cancer and other serious health effects, based on existing radiation dose models and on epidemiological cohort studies, to compare doses to tissues and anatomic sites of particular concern among workers performing similar types of procedures in the same or different facilities, and to develop biologically relevant radiation risk protection measures.
The currently active cohort follow-up studies of Canadian medical radiation workers and U.S. radiologic technologists should be extended to assess lifetime risks of cancer and other serious diseases. It will be important to apply the recently available individual cumulative occupational radiation dose estimates (83) to assess dose response in relation to cancer risks and other serious disease outcomes in the U.S. radiologic technologists.
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New large epidemiological cohort studies are urgently needed to evaluate cancer and other serious radiationrelated disease risks (e.g., benign tumors, such as meningiomas and schwannomas, cardiovascular diseases and cataracts) in interventional radiologists, cardiologists and physicians in other specialties who perform fluoroscopically guided procedures. We have undertaken a new cohort mortality study comparing cancer and other serious disease outcomes in 44,000 physicians performing fluoroscopically guided procedures (including interventional radiologists, cardiologists, neuroradiologists and others) and in 42,000 non-interventional radiologists with risks in 101,000 physicians who are unlikely to be occupationally exposed to radiation (e.g., family physicians and psychiatrists). Because doses to operators performing fluoroscopically guided interventional procedures correlate highly with patient doses (114, 115) , cohort studies that evaluate radiation doserelated cancer risks in interventional physicians may provide data that can be extrapolated to patient risks (albeit recognizing the notable differences between medical radiation workers, who are generally healthy, and patients, who are often ill) as well as mechanistic insights on cancer risks associated with chronic, fractionated, low-and moderate-dose radiation exposures.
